Gain Therapeutics, Inc.

Contributing Author

Recent Articles by Gain Therapeutics, Inc.

Jul-24	Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference GANX GlobeNewswire
Jul-16	Gain Therapeutics Announces Pricing of $7.0 Million Public Offering GANX GlobeNewswire
Jul-15	Gain Therapeutics Announces Proposed Public Offering GANX GlobeNewswire
Jun-30	Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson's Disease With or Without a GBA1 Mutation GANX GlobeNewswire
Jun-10	Gain Therapeutics to Participate in Upcoming Investor Conferences GANX GlobeNewswire
May-29	Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting GANX GlobeNewswire
May-14	Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update GANX GlobeNewswire
May-12	Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson's Disease and Related Disorders GANX GlobeNewswire